Noesis Capital Mangement Corp held its stake in Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,643 shares of the company’s stock at the close of the 2nd quarter. Noesis Capital Mangement Corp’s holdings in Colgate-Palmolive were worth $344,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. American Beacon Advisors Inc. acquired a new stake in shares of Colgate-Palmolive during the 1st quarter valued at approximately $102,000. Proficio Capital Partners LLC lifted its position in shares of Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after acquiring an additional 207 shares during the period. OLD Second National Bank of Aurora acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at approximately $109,000. Harbour Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the 1st quarter valued at approximately $121,000. Finally, Hanson & Doremus Investment Management lifted its position in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares during the period. 73.87% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This report was first reported by Watch List News and is the property of of Watch List News. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.watchlistnews.com/colgate-palmolive-company-cl-stake-maintained-by-noesis-capital-mangement-corp/1699327.html.

A number of equities research analysts have recently issued reports on CL shares. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price target for the company in a research report on Monday, September 25th. SunTrust Banks, Inc. upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $65.00 to $85.00 in a research report on Wednesday, October 11th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Jefferies Group LLC restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Finally, Deutsche Bank AG restated a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a research report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $76.67.

Shares of Colgate-Palmolive Company (CL) opened at $73.21 on Monday. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The firm has a market cap of $64,286.08, a price-to-earnings ratio of 25.51, a P/E/G ratio of 3.35 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the previous year, the business posted $0.73 EPS. The firm’s revenue was up 2.8% compared to the same quarter last year. analysts anticipate that Colgate-Palmolive Company will post 2.88 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

In other news, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total value of $273,867.85. Following the sale, the insider now owns 53,173 shares in the company, valued at approximately $3,799,210.85. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the sale, the director now owns 36,268 shares in the company, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. Insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.